Declines seen for low-value, not high-value tests; causality still an open question, though
The overall decline in diagnostic cardiovascular testing over the past decade may be attributed to drops in low-value tests, not high-value ones, researchers said -- seen as a win for Medicare payment reforms beginning 15 years ago.